SentreHEART, Inc., a Redwood City, CA-based medical device, has completed a $26m Series C financing.
The round was led by Vivo Ventures, with participation from existing investors US Venture Partners and Prospect Ventures.
Led by President and Chief Executive Officer Paul Buckman, SentreHEART manufactures the LARIAT Suture Delivery Device, which enables physicians to remotely deliver a 40mm pre-tied suture loop for immediate and complete soft tissue closure through access as small as 4.3mm and with no metal, clips or fabrics left behind.
Regulatory clearance for soft tissue ligation and approximation has been received in the US, Europe, and Canada.
In conjunction with the funding, the company has added Chen Yu, Managing Partner from Vivo Ventures, to its board of directors.